The FDA announced that it will “rapidly” work to grant emergency use authorization for Moderna’s coronavirus vaccine. The announcement follows an independent review by an FDA advisory panel, which recommended approving the vaccine yesterday. Once approved, Moderna’s vaccine will be the second coronavirus vaccine to receive emergency use authorization in the US.
Extra: The US government has purchased 200M doses of Moderna’s vaccine, of which 20M will be received by the end of this year.
The New Paper
This story is from the December 18, 2020 edition of The New Paper – a clear, concise daily briefing that makes fact-first news easy to consume. Try it today.
